Histogenics CEO Shankar Musunuri's 2020 pay jumps 171% to $1.6M
Histogenics reports 2020 executive compensation
By ExecPay News
Published: April 28, 2021
Histogenics reported fiscal year 2020 executive compensation information on April 28, 2021.
In 2020, four executives at Histogenics received on average a compensation package of $836K, a 83% increase compared to previous year.
Average pay of disclosed executives at Histogenics
Shankar Musunuri, Chief Executive Officer, received $1.6M in total, which increased by 171% compared to 2019. 50% of Musunuri's compensation, or $772K, was in option awards. Musunuri also received $269K in bonus, $500K in salary, as well as $11K in other compensation.
Sanjay Subramanian, Chief Financial Officer, received a compensation package of $662K. 55% of the compensation package, or $365K, was in salary.
Rasappa Arumugham, Chief Scientific Officer, earned $591K in 2020, a 62% increase compared to previous year.
Daniel Jorgensen, Chief Medical Officer, received $537K in 2020, which increases by 24% compared to 2019.
Related executives
You may also like
Source: SEC filing on April 28, 2021.